Geneos Wealth Management Inc. Tekla Life Sciences Investors Transaction History
Geneos Wealth Management Inc.
- $2.88 Billion
- Q1 2025
A detailed history of Geneos Wealth Management Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 764 shares of HQL stock, worth $9,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
764
Previous 878
12.98%
Holding current value
$9,336
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.06MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.19MShares$39 Million1.12% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.13 Million0.17% of portfolio
-
Morgan Stanley New York, NY519KShares$6.34 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$5.72 Million0.25% of portfolio
-
Needham Investment Management LLC New York, NY379KShares$4.63 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...